Agile Therapeutics Inc is a women's health specialty pharmaceutical company. The Company is engaged in the development and commercialization of transdermal patch technology for use in contraception products.
Stock Price Prediction
Update at 5:00pm EST
3.201 - 3.231
3.231 - 3.25
2.937 - 2.976
2.976 - 2.999
2.976 - 3.039
3.039 - 3.077
as of: 2020-02-25 4:27:01 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.AGRX has closed above bottom band by 6.7%. Bollinger Bands are 59% wider than normal. The large width of the bands suggest high volatility as compared to AGRX's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.
2020-02-21 Is Agile Therapeutics (AGRX) Stock Outpacing Its Medical Peers This Year? Is (AGRX) Outperforming Other Medical Stocks This Year?
2020-02-20 Agile Therapeutics EPS misses by $0.02 Agile Therapeutics (NASDAQ:AGRX): Q4 GAAP EPS of -$0.10 misses by $0.02. Cash and equivalents of $34.5M. Shares -14.3%. Press Release
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.